PaxVax's Series B - II Round

PaxVax raised a round of funding on July 28, 2014.

PaxVax, founded in 2007, is a fully integrated specialty vaccine company with a mission to develop, manufacture and commercialize vaccines against infectious diseases in a socially responsible manner.…

Articles about PaxVax's Series B - II Round: